Literature DB >> 20882401

Increased levels of anxiety-related behaviors in a Tsc2 dominant negative transgenic mouse model of tuberous sclerosis.

Dan Ehninger1, Alcino J Silva.   

Abstract

Tuberous sclerosis (TSC) is a single-gene disorder caused by heterozygous mutations in the TSC1 or TSC2 gene. TSC is often associated with neurological (e.g., epilepsy), cognitive (intellectual disabilities, specific neuropsychological impairments) and behavioral pathologies (e.g., autism, attention deficit hyperactivity disorder). In addition, there is a high prevalence of psychiatric problems in TSC populations, including anxiety and mood disorders. To date, little is known about the pathogenetic bases of these associated psychiatric symptoms; for instance, it is unclear whether they are rooted in TSC-associated neurobiological alterations or whether they are secondary psychological phenomena (e.g., because individuals have to cope with the burden of the disease). Here, we report elevated levels of anxiety-related behaviors and mild deficits in two hippocampal-dependent learning tasks in a Tsc2 dominant negative transgenic mouse model of TSC. These findings establish a mouse model for TSC-related anxiety phenotypes and suggest that anxiety disorders in TSC have a biological foundation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20882401      PMCID: PMC3102774          DOI: 10.1007/s10519-010-9398-1

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  33 in total

1.  Genotype and psychological phenotype in tuberous sclerosis.

Authors:  J C Lewis; H V Thomas; K C Murphy; J R Sampson
Journal:  J Med Genet       Date:  2004-03       Impact factor: 6.318

2.  Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex.

Authors:  C Joinson; F J O'Callaghan; J P Osborne; C Martyn; T Harris; P F Bolton
Journal:  Psychol Med       Date:  2003-02       Impact factor: 7.723

3.  Cognitive deficits in normally intelligent patients with tuberous sclerosis.

Authors:  J E Harrison; F J O'Callaghan; E Hancock; J P Osborne; P F Bolton
Journal:  Am J Med Genet       Date:  1999-12-15

4.  Genetic identification of a locus, Mot1, that affects renal tumor size in the rat.

Authors:  R S Yeung; H Gu; M Lee; T A Dundon
Journal:  Genomics       Date:  2001-12       Impact factor: 5.736

5.  Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex.

Authors:  Patrick F Bolton; Rebecca J Park; J Nicholas P Higgins; Paul D Griffiths; Andrew Pickles
Journal:  Brain       Date:  2002-06       Impact factor: 13.501

6.  Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures.

Authors:  Erik J Uhlmann; Michael Wong; Rebecca L Baldwin; M Livia Bajenaru; Hiroaki Onda; David J Kwiatkowski; Kelvin Yamada; David H Gutmann
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

7.  Presence of a modifier gene(s) affecting early renal carcinogenesis in the Tsc2 mutant (Eker) rat model.

Authors:  Yasushi Kikuchi; Akemi Sudo; Hiroaki Mitani; Okio Hino
Journal:  Int J Oncol       Date:  2004-01       Impact factor: 5.650

8.  Morbidity associated with tuberous sclerosis: a population study.

Authors:  D W Webb; A E Fryer; J P Osborne
Journal:  Dev Med Child Neurol       Date:  1996-02       Impact factor: 5.449

9.  Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients.

Authors:  Sandra L Dabora; Penelope Roberts; Andres Nieto; Ron Perez; Sergiusz Jozwiak; David Franz; John Bissler; Elizabeth A Thiele; Katherine Sims; David J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2002-08-21       Impact factor: 11.025

10.  Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.

Authors:  Sharon W Way; James McKenna; Ulrike Mietzsch; R Michelle Reith; Henry Cheng-Ju Wu; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2009-01-15       Impact factor: 6.150

View more
  19 in total

1.  Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism.

Authors:  Jill L Silverman; Daniel G Smith; Stacey J Sukoff Rizzo; Michael N Karras; Sarah M Turner; Seda S Tolu; Dianne K Bryce; Deborah L Smith; Kari Fonseca; Robert H Ring; Jacqueline N Crawley
Journal:  Sci Transl Med       Date:  2012-04-25       Impact factor: 17.956

2.  Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin.

Authors:  Itzamarie Chévere-Torres; Jordan M Maki; Emanuela Santini; Eric Klann
Journal:  Neurobiol Dis       Date:  2011-07-30       Impact factor: 5.996

Review 3.  Behavioral and Neuroanatomical Phenotypes in Mouse Models of Autism.

Authors:  Jacob Ellegood; Jacqueline N Crawley
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

4.  NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model.

Authors:  Shu-Ichi Okamoto; Olga Prikhodko; Juan Pina-Crespo; Anthony Adame; Scott R McKercher; Laurence M Brill; Nobuki Nakanishi; Chang-Ki Oh; Tomohiro Nakamura; Eliezer Masliah; Stuart A Lipton
Journal:  Neurobiol Dis       Date:  2019-03-27       Impact factor: 5.996

5.  Altered learning, memory, and social behavior in type 1 taste receptor subunit 3 knock-out mice are associated with neuronal dysfunction.

Authors:  Bronwen Martin; Rui Wang; Wei-Na Cong; Caitlin M Daimon; Wells W Wu; Bin Ni; Kevin G Becker; Elin Lehrmann; William H Wood; Yongqing Zhang; Harmonie Etienne; Jaana van Gastel; Abdelkrim Azmi; Jonathan Janssens; Stuart Maudsley
Journal:  J Biol Chem       Date:  2017-05-18       Impact factor: 5.157

6.  Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex.

Authors:  Itzamarie Chévere-Torres; Hanoch Kaphzan; Aditi Bhattacharya; Areum Kang; Jordan M Maki; Michael J Gambello; Jack L Arbiser; Emanuela Santini; Eric Klann
Journal:  Neurobiol Dis       Date:  2011-12-16       Impact factor: 5.996

7.  Neuron subset-specific Pten deletion induces abnormal skeletal activity in mice.

Authors:  Joaquin N Lugo; Marjorie H Thompson; Philippe Huber; Gregory Smith; Ronald Y Kwon
Journal:  Exp Neurol       Date:  2017-02-02       Impact factor: 5.330

Review 8.  The age of anxiety: role of animal models of anxiolytic action in drug discovery.

Authors:  John F Cryan; Fabian F Sweeney
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

9.  Prenatal rapamycin results in early and late behavioral abnormalities in wildtype C57BL/6 mice.

Authors:  Peter T Tsai; Emily Greene-Colozzi; June Goto; Stefanie Anderl; David J Kwiatkowski; Mustafa Sahin
Journal:  Behav Genet       Date:  2012-12-12       Impact factor: 2.805

Review 10.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.